🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Stock Summary and Key Metrics













Investment Checklist




























Forecasts

No ConstituentsNo Constituents

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Standalone Quarterly Results (in ₹ Crores)

Total Figures
QoQ Changes
Total Figures
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales6.898.006.838.16101016121720
Expenses6.156.245.347.268.888.7915111619
Operating Profit0.741.761.490.901.381.661.231.251.361.53
OPM %10.7422.0021.8211.0313.4515.897.6510.338.027.54
Other Income0.000.00-0.050.010.000.010.060.010.000.01
Interest0.050.060.040.080.180.200.170.160.160.15
Depreciation0.430.260.260.260.260.250.250.250.260.26
Profit Before Tax0.251.441.130.570.941.220.860.850.951.11
Tax %28.0032.6471.6826.3210.6416.3927.9125.8826.3226.13
Net Profit0.190.960.320.420.841.020.630.630.700.82
EPS in Rs0.281.500.500.651.301.580.970.981.091.28

Standalone Profit Loss (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales17111415252220274549
Expenses149.451111211816234043
Operating Profit3.301.542.973.844.183.763.574.465.145.52
OPM %18.9413.9920.8825.4216.7917.4618.0616.3411.4511.29
Other Income0.010.010.000.020.330.490.01-0.040.08NaN
Interest0.060.210.160.160.100.150.240.190.620.71
Depreciation0.350.350.340.340.370.420.621.041.021.01
Profit Before Tax1.410.831.061.854.033.682.743.183.583.87
Tax %0.383.752.7811.2416.3133.9322.4745.3618.9619.38
Net Profit1.400.801.031.643.372.432.121.742.903.12
EPS in Rs2.191.241.592.555.244.313.512.704.504.32
Dividend Payout %0.000.0062.890.000.000.000.000.000.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital6.446.446.446.446.446.446.446.446.446.44
Reserves-0.880.531.332.363.356.739.16111316
Borrowings0.081.911.770.161.120.930.040.020.007.41
Other Liabilities0.982.651.561.842.233.133.693.714.196.07
Total Liabilities6.62121111131719212436
Fixed Assets3.313.533.583.573.313.885.006.565.524.59
CWIP0.000.000.000.000.000.340.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.00
Other Assets3.317.997.527.239.821314151831
Total Assets6.62121111131719212436

Standalone Cash Flows (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity2.64-0.364.46-0.702.512.690.07
Cash from Investing Activity-0.31-0.71-2.090.070.060.29-5.33
Cash from Financing Activity-1.600.320.32-1.20-0.53-0.045.40
Net Cash Flow0.74-0.742.69-1.832.042.950.13

Documents

Presentations
Concalls
Reports
Presentations

No documents found!

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Source Natural Foods & Herbal Supplements Ltd

Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) is currently trading at 128.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Source Natural Foods & Herbal Supplements Limited is a business engaged in the production and sale of allopathic and ayurvedic formulations. The company focuses deeply on R&D to diversify its product portfolio, especially in creating herbal and organic nutritional supplements. Its key products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets, aiming to integrate Ayurveda into daily diets. Despite operational challenges, such as factory shutdowns due to insufficient working capital, the company revived under new management focusing on high-quality Ayurveda products.

Over the past 52 weeks, Source Natural Foods & Herbal Supplements Ltd has traded between a low of ₹120.35 and a high of ₹216.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Source Natural Foods & Herbal Supplements Ltd has a market capitalization of approximately 82.36. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Source Natural Foods & Herbal Supplements Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 29.63 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 82.36 Cr, Source Natural Foods & Herbal Supplements Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Source Natural Foods & Herbal Supplements Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Source Natural Foods & Herbal Supplements Ltd is 29.63. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.